Evidence map›Paper›PMID 8388172›Full record

ArticleThe American journal of pathology1993

Altered integrin expression in adenocarcinoma of the breast. Analysis by in situ hybridization.

M M Zutter, H R Krigman, S A Santoro

Open access · greenAbstract readComparative Study
In one paragraph

Article in The American journal of pathology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Depletion ofBiomedicines · 2022
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Integrin function in breast carcinoma progression.Journal of mammary gland biology and neoplasia · 1999
    Review
  15. Article
  16. Article
  17. Tissue architecture: the ultimate regulator of epithelial function?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 1998
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M M ZutterDepartment of Pathology, Washington University School of Medicine, St. Louis, MO 63110.
H R Krigman
S A Santoro
Washington University in St. Louis · US

Funding

WASHINGTON UNIVERSITY FELLOWSHIP IN BLOOD BANKINGT32HL007038 · NHLBI · WASHINGTON UNIVERSITY · PI LUBLIN, DOUGLAS M · 1985 to 1994
–
NHLBI NIH HHS T32-HL07038
6 · The paper itself

Abstract

The integrin superfamily of adhesion receptors mediates interactions between cells and the extracellular matrix. Our earlier immunohistochemical analysis showed that normal mammary epithelium expressed high levels of the alpha 2 beta 1 collagen/laminin receptor and intermediate levels of the alpha 5 beta 1 fibronectin receptor. In contrast, malignant cells of adenocarcinoma of the breast exhibited marked diminution or loss of the alpha 2 beta 1 and alpha 5 beta 1 integrins. We have now evaluated the level of alpha 2, alpha 5, and beta 1 integrin subunit messenger (m)RNA by in situ hybridization in adenocarcinoma of the breast. Normal breast ducts and ductules expressed high levels of all three integrin subunit mRNAs. Poorly differentiated lesions expressed low to undetectable levels of alpha 2, alpha 5, and beta 1 mRNA. Well- and moderately differentiated lesions expressed all three subunits at intermediate levels. Thus, decreased expression of the alpha 2 beta 1 and alpha 5 beta 1 integrins in mammary carcinoma is the result of decreased steady-state integrin subunit mRNA levels due to altered expression of the integrin genes.

Indexed as

AdenocarcinomaBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingHumansImmunohistochemistryIn Situ HybridizationIntegrinsNeoplasm InvasivenessReference ValuesRNA, MessengerIntegrinsRNA, Messenger

Identifiers

PMID8388172
PMCPMC1886906
OpenAlexW629619092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.